(Q46194088)

20 December 2017

title

Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas (English)

1 reference

20 December 2017

1 reference

Yoh Dobashi

1

1 reference

20 December 2017

Shioto Suzuki

2

1 reference

20 December 2017

Hirochika Matsubara

3

1 reference

20 December 2017

Maiko Kimura

4

1 reference

20 December 2017

Shunsuke Endo

5

1 reference

20 December 2017

Akishi Ooi

6

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

20 December 2017

published in

Cancer

1 reference

20 December 2017

volume

115

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

107-118

1 reference

20 December 2017

Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Epidermal growth factor receptor mutations in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Diversity of epidermal growth factor receptor-mediated activation of downstream molecules in human lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

mTOR, translation initiation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

TOR signaling in growth and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

mTOR signaling: implications for cancer and anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Inhibition of mammalian target of rapamycin or apoptotic pathway induces autophagy and radiosensitizes PTEN null prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

AKT activation in human glioblastomas enhances proliferation via TSC2 and S6 kinase signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

Targeting tyrosine kinases in cancer: the second wave

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

inferred from DOI database lookup

7 January 2021

based on heuristic

The World Health Organization histological typing of lung tumours. Second edition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

inferred from DOI database lookup

7 January 2021

based on heuristic

Correlation between EGFR gene mutation pattern and Akt phosphorylation in pulmonary adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23996

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.23996

1 reference

20 December 2017

1 reference

20 December 2017